Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DVC1-0101 for Intermittent Claudication Secondary to Peripheral Artery Disease
NCT02276937Phase 2Unknown
- Sponsor
- Kyushu University
- Start
- Oct 2014
- Primary completion
- Dec 2021
- Modality
- Gene Editing, Gene Silencing, Gene Addition/Replacement
- Countries
- 1
01
Overview
A Phase 2 trial of DVC1-0101 in Peripheral Arterial Disease (PAD), intermittent claudication (IC), sponsored by Kyushu University. Status: unknown.
02
Drugs
DVC1-0101
03
Conditions
Peripheral Arterial Disease (PAD)intermittent claudication (IC)
Beyond the preview
Go deeper on NCT02276937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02276937.